Search Results - "Ford, A W"
-
1
Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2
Published in The Journal of pharmacology and experimental therapeutics (01-02-2001)“…We report here the preclinical profile of etoricoxib (MK-0663) [5-chloro-2-(6-methylpyridin-3-yl)-3-(4-methylsulfonylphenyl) pyridine], a novel orally active…”
Get more information
Journal Article -
2
Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX‐2 inhibitor
Published in British journal of pharmacology (01-05-1997)“…DFU (5,5‐dimethyl‐3‐(3‐fluorophenyl)‐4‐(4‐methylsulphonyl)phenyl‐2(5H)‐furanone) was identified as a novel orally active and highly selective cyclo‐oxygenase‐2…”
Get full text
Journal Article -
3
Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach
Published in The Journal of pharmacology and experimental therapeutics (01-09-1995)“…Recent studies have shown that there are two isoforms of cyclooxygenases. The constitutive form, cyclooxygenase 1 (COX-1), is believed to be involved in the…”
Get more information
Journal Article -
4
Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles
Published in The Journal of pharmacology and experimental therapeutics (01-08-1999)“…The discoveries that cyclooxygenase (COX)-2 is an inducible form of COX involved in inflammation and that COX-1 is the major isoform responsible for the…”
Get more information
Journal Article -
5
The discovery of rofecoxib, [MK 966, VIOXX ®, 4-(4′-methylsulfonylphenyl)-3-phenyl-2(5 H)-furanone], an orally active cyclooxygenase-2 inhibitor
Published in Bioorganic & medicinal chemistry letters (05-07-1999)“…The development of a COX-2 inhibitor rofecoxib (MK 966, Vioxx®) is described. It is essentially equipotent to indomethacin both in vitro and in vivo but…”
Get full text
Journal Article -
6
Alterations in P2X and P2Y purinergic receptor expression in urinary bladder from normal cats and cats with interstitial cystitis
Published in American journal of physiology. Renal physiology (01-11-2004)“…Purinergic mechanisms appear to be involved in motor as well as sensory functions in the urinary bladder. ATP released from efferent nerves excites bladder…”
Get more information
Journal Article -
7
Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist
Published in Canadian journal of physiology and pharmacology (01-01-1989)“…L-660,711 (3-(3-(2-(7-chloro-2-quinolinyl)ethenyl)phenyl) ((3-dimethyl amino-3-oxo propyl)thio)methyl)thio)propanoic acid is a potent and selective competitive…”
Get more information
Journal Article -
8
A Pig Collagen Peptide Fraction. A Unique Material for Maintaining Biological Activity During Lyophilization and During Storage in the Liquid State
Published in Journal of pharmacy and pharmacology (01-09-1996)“…There is frequent use of human and animal proteins as stabilizers during lyophilization of a variety of biological substances with a view to long term stable…”
Get full text
Journal Article -
9
Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist
Published in Canadian journal of physiology and pharmacology (01-02-1995)“…Montelukast sodium (Singulair), also known as MK-0476 (1-(((1(R)-(3-(2-(7-chloro-2-quinolinyl)-(E)-ethenyl)phenyl)(3-2-(1-…”
Get more information
Journal Article -
10
Increased urinary LTE4 excretion following inhalation of LTC4 and LTE4 in asthmatic subjects
Published in The European respiratory journal (01-05-1994)“…Urinary leukotriene E4 (LTE4) increases during exacerbations of asthma and following antigen challenge. We determined whether urinary LTE4 excretion reflects…”
Get full text
Journal Article -
11
The allergens of dog. II. Identification and partial purification of a major dander allergen
Published in Clinical and experimental allergy (01-08-1992)“…A dog hair and dander (DHD) extract was prepared from hair obtained from mixed breeds. By SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting,…”
Get more information
Journal Article -
12
Growth and neurodevelopmental outcome in extremely-low-birth-weight infants after laparotomy
Published in Pediatric surgery international (01-09-1999)“…Twenty-one extremely-low-birth-weight (ELBW) and premature infants (<29 weeks' gestation and/or <1,000 g) underwent emergency laparotomy for acute…”
Get full text
Journal Article -
13
Stereospecific synthesis, assignment of absolute configuration, and biological activity of the enantiomers of 3-[[[3-[2-(7-chloroquinolin-2-yl)-(E)-ethenyl]phenyl][[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]propionic acid, a potent and specific leukotriene D4 receptor antagonist
Published in Journal of medicinal chemistry (01-10-1990)“…The enantiomers of the leukotriene D4 antagonist 3-[[[3-[2-(7-chloroquinolin-2-yl)-(E)-ethenyl]phenyl]…”
Get full text
Journal Article -
14
Effect of altitude on urinary leukotriene (LT) E4 excretion and airway responsiveness to histamine in children with atopic asthma
Published in The European respiratory journal (01-03-1995)“…Asthmatic subjects who are resident at altitude may experience a deterioration in lung function following a stay at sea level. To determine whether measurement…”
Get full text
Journal Article -
15
The effect of carbohydrate additives in the freeze-drying of alkaline phosphatase
Published in Journal of pharmacy and pharmacology (01-02-1993)“…Alkaline phosphatase was used as a model in studies to assess the effects of lyophilization on biological activity and molecular integrity in the presence or…”
Get more information
Journal Article -
16
Characterization of the recombinant human prostanoid DP receptor and identification of L‐644,698, a novel selective DP agonist
Published in British journal of pharmacology (01-04-1998)“…A human embryonic kidney cell line [HEK 293(EBNA)] stably expressing the human recombinant prostaglandin D2 (PGD2) receptor (hDP) has been characterized with…”
Get full text
Journal Article -
17
Increased urinary leukotriene excretion in patients with cardiac ischemia : in vivo evidence for 5-lipoxygenase activation
Published in Circulation (New York, N.Y.) (1992)“…Experimental cardiac ischemia in some animal models results in the activation of the enzyme 5-lipoxygenase and the subsequent production of leukotrienes,…”
Get full text
Conference Proceeding Journal Article -
18
Innovations in drug research: inhibitors of thromboxane and leukotrienes
Published in Clinical and experimental allergy (01-05-1991)Get more information
Journal Article -
19
L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2 - dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor
Published in Canadian journal of physiology and pharmacology (01-05-1989)“…L-663,536 (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2, 2-dimethylpropanoic acid) is a potent inhibitor of leukotriene (LT) biosynthesis in…”
Get more information
Journal Article -
20
Antenatal betamethasone and favourable outcomes in fetuses with 'poor prognosis' diaphragmatic hernia
Published in Pediatric surgery international (01-05-2002)“…Congenital diaphragmatic hernia (CDH) is a common abnormality affecting 1 in 2,000 gestations. The mortality exceeds 50% despite recent advances in postnatal…”
Get full text
Journal Article